| Financial Year |
March 31 2023 |
| Monetary Funds |
1,508,356,599.95 |
| Held-for-trading Financial Assets |
63,848,010.66 |
| Notes Receivable |
-- |
| Accounts Receivable |
185,518,637.71 |
| Advances to Suppliers |
791,250,338.66 |
| Other Receivables |
401,049,785.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,174,213,038.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
484,351,352.88 |
| Total Current Assets |
4,608,587,764.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
268,365,235.91 |
| Long-term Equity Investment |
6,746,012,584.13 |
| Investment Properties |
3,223,664,024.77 |
| Fixed Assetes |
5,091,899,419.94 |
| Under-construction Projects |
2,633,529,404.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,399,057,963.98 |
| R&D expenses |
7,404,527.16 |
| Goodwill |
284,916,367.87 |
| Long-Term Deferred and Prepaid Expenses |
287,633,609.69 |
| Deferred Income Tax Assets |
131,775,136.19 |
| Other Non-Current Assets |
147,383,378.37 |
| Sub-Total of Non-Current Assets |
27,506,433,677.26 |
| Total Assets |
32,115,021,441.26 |
| Short-Term Loans |
1,354,519,583.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
653,195,968.58 |
| Accounts Received In Advance |
821,022,695.92 |
| Employee Compensation Payable |
79,609,632.35 |
| Taxes Payable |
94,518,042.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,344,323,840.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
108,675,597.91 |
| Other Current Liabilities |
3,363,513,924.63 |
| Sub-Total of Current Liabilities |
11,060,543,570.28 |
| Long-term Loans |
436,700,000.00 |
| Bonds Payable |
3,497,672,189.14 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
110,620,306.10 |
| Deferred Income Tax Liabilities |
94,889,138.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,507,075,523.38 |
| Total Liabilities |
15,567,619,093.66 |
| Paid-In Capital(Or Share Stock) |
5,486,074,176.00 |
| Capital Surplus |
1,654,775,872.61 |
| Surplus Reserve |
1,616,083,136.73 |
| LESS:Treasury Stock |
80,753,291.00 |
| Undistributed Profits |
7,873,597,957.57 |
| Minority Stockholder's Interest |
8,918,417.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,538,483,930.21 |
| Owner's Equity（Stockholder's Equity） |
16,547,402,347.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
32,115,021,441.26 |
